We are pleased to announce that ARMOR PHARMA successfully passed the annual EXCiPACT surveillance audit in April 2018.
ARMOR PHARMA’s facility was first EXCiPACT certified in 2016.
This certification ensures that ARMOR PHARMA’s activity complies with the quality standards for pharmaceutical excipients. A surveillance audit has been conducted on April 17th at our Loudéac production site, France and confirms that the requirements of excipient Good Manufacturing Practices (GMPs) continue to be met.
EXCiPACT™ is a voluntary program developed by the EFCG, IPEC Europe, IPEC Americas, FECC and PQG;
It is a 3rd party certification scheme for manufacturers, suppliers and distributors of pharmaceutical excipients, aligned to the ISO 9001 quality system certification; and NSF/IPEC/ANSI 363-2014: Good Manufacturing Practices (GMP) for Pharmaceutical Excipients.
More information on www.excipact.org